This project will employ fluorescent imaging technology and biochemistry to
investigate kinetic parameters and nuclear organization in epithelial cells
of the rat mammary glands that are refractory to chemical carcinogens. Our
aim will be accomplished by (1) defining and comparing the cell kinetics of
the proliferative compartment in carcinogen sensitive mammary glands of
virgin rats with mammary glands of animals made resistant to carcinogens by
hormone treatment, 2) defining the topology and identifying the stages of
the cell cycle of cells in the refractory glands and (3) characterizing
nuclear domains and nuclear matrix protein patterns in mammary epithelial
cells in the susceptible, resistant and malignant states. Our specific
aims are to identify and characterize the proliferative compartment in the
mammary gland of mature virgin and hormone treated rats and to determine
the changes in the kinetics of proliferation after MNU treatment, and to
identify structural changes in nuclear domains and characterize proteins of
the nuclear matrix that may be specifically expressed in the mature virgin
mammary glands and glands of animals made refractory to carcinogens after
hormone treatment. The nuclear matrix proteins will also b analyzed in
carcinogen-induced intraductal proliferations and in mammary
adenocarcinoma. Antibodies will be made to nuclear matrix proteins which
are unique to mammary epithelial cells of the resistant gland and to
nuclear matrix proteins unique to adenocarcinoma cells. The antibodies
will be used to characterize the topology of the cells of the resistant
state and to follow the distribution and fate of resistant cells and
adenocarcinoma cells.
No Sub Projects information available for 3P01CA064255-05S1 0002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P01CA064255-05S1 0002
Patents
No Patents information available for 3P01CA064255-05S1 0002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P01CA064255-05S1 0002
Clinical Studies
No Clinical Studies information available for 3P01CA064255-05S1 0002
News and More
Related News Releases
No news release information available for 3P01CA064255-05S1 0002
History
No Historical information available for 3P01CA064255-05S1 0002
Similar Projects
No Similar Projects information available for 3P01CA064255-05S1 0002